These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Use of aspirin in ischemic heart disease]. Frishman W; Horwitz S Arch Inst Cardiol Mex; 1977; 47(2):129-31. PubMed ID: 901049 [No Abstract] [Full Text] [Related]
26. The use of aspirin in ischemic heart disease. Willard JE; Lange RA; Hillis LD N Engl J Med; 1992 Jul; 327(3):175-81. PubMed ID: 1285747 [No Abstract] [Full Text] [Related]
28. Acute coronary syndromes. Norris RM N Z Med J; 2004 Aug; 117(1200):U1031; author reply U1031. PubMed ID: 15475997 [No Abstract] [Full Text] [Related]
29. Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks. De Caterina R Ital Heart J; 2003 Apr; 4(4):228-31. PubMed ID: 12784774 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic interventions which may improve survival in patients with coronary artery disease. Boudoulas H Acta Cardiol; 1990; 45(6):477-87. PubMed ID: 1981414 [No Abstract] [Full Text] [Related]
32. [Antiplatelet therapy in acute coronary syndromes without ST segment elevation]. Umman B Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():13-9. PubMed ID: 16613770 [TBL] [Abstract][Full Text] [Related]
33. Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction. Becker RC Arch Pathol Lab Med; 1993 Jan; 117(1):89-96. PubMed ID: 8418769 [TBL] [Abstract][Full Text] [Related]
34. [Acetosal and the heart]. Verheugt FW Ned Tijdschr Geneeskd; 1984 Oct; 128(41):1951-3. PubMed ID: 6504178 [No Abstract] [Full Text] [Related]
35. [Coronary disease: benefits of aspirin. What dose for which disease?]. Michel PL Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):204-10. PubMed ID: 8024235 [TBL] [Abstract][Full Text] [Related]
36. Aspirin for prevention of myocardial infarction and stroke. Med Lett Drugs Ther; 1989 Aug; 31(799):77-9. PubMed ID: 2671622 [No Abstract] [Full Text] [Related]
37. Thrombolytic, antithrombin, and antiplatelet treatment of acute coronary syndromes. Puma JA; Sketch MH J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S8-12. PubMed ID: 11191119 [TBL] [Abstract][Full Text] [Related]
39. Translational therapeutics at the platelet vascular interface. Summary. FitzGerald GA Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s51-2. PubMed ID: 18296588 [No Abstract] [Full Text] [Related]
40. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?]. Rupprecht HJ MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]